DXB 2.83% 54.5¢ dimerix limited

Ann: Quarterly Appendix 4C and Activities Report, page-37

  1. 100 Posts.
    lightbulb Created with Sketch. 21
    Have you even read this paper you illiterate blind bat??? Steroids are the first line treatment. ACE inhibitors are recommended for use but not the standard of care. I don't even know why I am replying to you and wasting my time.

    I trust you stay friends with that nephrologist mate of yours after this stock takes off.


    read this and weep:
    30 publications were selected; 5 were controlled trials (4 randomized controlled trials). 8 assessed RAAS inhibitor monotherapy, while the rest studied RAAS inhibitors in combination with other drugs, mainly immunosuppressants. On average, a 32% proteinuria reduction (ROM, 0.68; 95% CI, 0.47-0.98) and no change in creatinine clearance (ROM, 0.95; 95% CI, 0.77-1.16) from baseline to the last reported follow-up was observed in patients treated with RAAS inhibitor monotherapy. When a RAAS inhibitor was combined with other drugs, a 72% proteinuria reduction was observed from baseline to the last reported follow-up (ROM, 0.24; 95% CI, 0.08-0.75). The published data did not allow for the assessment of the effects of RAAS inhibitor monotherapy on estimated glomerular filtration rate and end-stage kidney disease risks.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065901/




 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
54.5¢
Change
0.015(2.83%)
Mkt cap ! $299.6M
Open High Low Value Volume
53.0¢ 54.5¢ 52.0¢ $905.8K 1.698M

Buyers (Bids)

No. Vol. Price($)
1 8606 53.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 72714 5
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.